Risks of serious complications and death from smallpox vaccination: A systematic review of the United States experience, 1963–1968

BACKGROUND: The United States (US) has re-instituted smallpox vaccinations to prepare for an intentional release of the smallpox virus into the civilian population. In an outbreak, people of all ages will be vaccinated. To prepare for the impact of large-scale ring and mass vaccinations, we conducted a systematic review of the complication and mortality risks of smallpox vaccination. We summarized these risks for post-vaccinial encephalitis, vaccinia necrosum (progressive vaccinia), eczema vaccinatum, generalized vaccinia, and accidental infection (inadvertant autoinoculation). METHODS: Using a MEDLINE search strategy, we identified 348 articles, of which seven studies met our inclusion criteria (the number of primary vaccinations and re-vaccinations were reported, sufficient data were provided to calculate complication or case-fatality risks, and comparable case definitions were used). For each complication, we estimated of the complication, death, and case-fatality risks. RESULTS: The life-threatening complications of post-vaccinial encephalitis and vaccinia necrosum were at least 3 and 1 per million primary vaccinations, respectively. Twenty-nine percent of vaccinees with post-vaccinial encephalitis died and 15% with vaccinia necrosum died. There were no deaths among vaccinees that developed eczema vaccinatum; however, 2.3% of non-vaccinated contacts with eczema vaccinatum died. Among re-vaccinees, the risk of post-vaccinial encephalitis was reduced 26-fold, the risk of generalized vaccinia was reduced 29-fold, and the risk of eczema vaccinatum was reduced 12-fold. However, the risk reductions of accidental infection and vaccinia necrosum were modest (3.8 and 1.5 fold respectively)

Five-year monitoring of a gay-friendly voluntary counselling and testing facility in Switzerland: who got tested and why?

ABSTRACT: BACKGROUND: An increase in new HIV cases among men who have sex with men (MSM) has been reported in Switzerland since 2001. A rapid result HIV testing for MSM through voluntary counselling and testing (VCT) facility ("Checkpoint") was opened in Geneva in 2005. This gay-friendly facility, the first to open in Switzerland, provides testing for sexually transmitted infections (STI) and rapid result HIV testing and counselling. Our objective was to analyze Checkpoint's activity over its first five years of activity and its ability to attract at-risk MSM. METHODS: We used routine data collected anonymously about the facility activity (number of clients, number of tests, and test results) and about the characteristics of the clientele (sociodemographic data, sexual risk behaviour, and reasons for testing) from 2005 to 2009. RESULTS: The yearly number of HIV tests performed increased from 249 in 2005 to 561 in 2009. The annual proportion of positive tests among tests performed varied between 2% and 3%. Among MSM clients, the median annual number of anal intercourse (AI) partners was three. Roughly 30% of all MSM clients had at least one unprotected anal intercourse (UAI) experience in the previous 12 months with a partner of different/unknown HIV status.The main reason for testing in 2007, 2008, and 2009 was "sexual risk exposure" (~40%), followed by "routine" testing (~30%) and "condom stopping in the beginning of a new steady relationship" (~10%). Clients who came to the facility after a sexual risk exposure, compared to clients who came for "routine testing" or "condom stopping" reasons, had the highest number of AI partners in the previous 12 months, were more likely to have had UAI with a partner of different/unknown HIV status in the previous 12 months (respectively 57.3%, 12.5%, 23.5%), more likely to have had an STI diagnosed in the past (41.6%, 32.2%, 22.9%), and more likely to report recent feelings of sadness or depression (42.6%; 32.8%, 18.5%). CONCLUSION: Many of Checkpoint's clients reported elevated sexual risk exposure and risk factors, and the annual proportion of new HIV cases in the facility is stable. This VCT facility attracts the intended population and appears to be a useful tool contributing to the fight against the HIV epidemic among MSM in Switzerland

Preditores de soropositividade para HIV em indivíduos não abusadores de drogas que buscam centros de testagem e aconselhamento de Porto Alegre, Rio Grande do Sul, Brasil Predictors of HIV seropositive status in non-IV drug users at testing and counseling centers in Porto Alegre, Rio Grande do Sul, Brazil

Este estudo descreve comportamentos de risco para HIV, obtidos através de questionário, em 570 indivíduos de Porto Alegre que não usavam drogas regularmente. A idade média foi 30,3, 51,1 % eram homens, e a maioria tinha baixa renda (59,1%). A soropositividade foi de 9,9% (13,1% entre homens e 6,9% entre mulheres), associada a sexo masculino, ter mais de 30 anos e baixa renda. Mulheres reportaram mais sexo desprotegido (86,4%) do que homens (74,4%) e mais sexo com usuários de droga injetável (11,6% versus 2,1%); homens relataram mais sexo homossexual desprotegido (18,7% versus 1,4%) e mais relações com profissionais de sexo (19,0% versus 0,4%). Não houve associação entre uso eventual de drogas e soropositividade. A idade associada à soropositividade confirma achados anteriores, indicando maior exposição a riscos durante a vida. O estudo confirma a pauperização da epidemia, com indivíduos pobres apresentando maior soropositividade. Homens e mulheres apresentaram diferentes comportamentos associados à soropositividade, confirmando a necessidade de prevenção específica e distinta para cada grupo.<br>This study describes HIV-related behaviors recorded through a questionnaire applied to 570 individuals in Porto Alegre, Rio Grande do Sul, Brazil, who were not regular drug users. Mean age was 30.3 years, 51.1 % were male, and most were low-income (59.1%). The HIV seropositive rate was 9.9% (13.1% for males, 6.9% for females), and there was a positive association with male gender, age over 30 years, and low income. Women reported more unprotected sex (86.4%) than men (74.4%) and more sex involving drugs (11.6% vs. 2.1%); men reported more unprotected homosexual sex (18.7% vs. 1.4%) and more sex with sex workers (19.0% vs. 0.4%). There was no association between sporadic drug use and seropositive status. The association between age and seropositive status confirms previous findings, indicating more lifetime risk exposure. The study confirms the so-called pauperization of the epidemic, with poor individuals showing a higher seropositive rate. Males and females showed different behaviors associated with seropositive status, confirming the need for specific and differentiated preventive strategies for each group

Running in place: Implications of HIV incidence estimates among urban men who have sex with men in the United States and other industrialized countries

Attempts to document changing HIV incidence rates among MSM are compromised by issues of generalizability and statistical power. To address these issues, this paper reports annualized mean HIV incidence rates from the entire published incidence literature on MSM from Europe, North America and Australia for the period 1995-2005. Publications that met the entry criteria were coded for region of the world, sampling method and year of study. From these reports, we calculated a mean incidence rate with confidence intervals for these variables. Although no differences in mean incidence rates were found for MSM from 1995 to 2005, HIV incidence rates are lower in Australia than either North America or Europe. We calculated a mean incidence rate of 2.39% for MSM in the United States, which if sustained within a cohort of MSM, would yield HIV prevalence rate of approximately 40% at age 40. These extrapolations overlap published HIV prevalence rates for MSM younger than age 40 in the United States. HIV incidence rates in the 2-3% range will adversely affect the health of gay male communities for decades to come. This analysis suggests that greater attention should be devoted to the question of how best to design prevention interventions that will lower HIV incidence rates among gay men. © 2009 Springer Science+Business Media, LLC